Position in HOWL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$120,893
-$203,548 QoQ
Shares Held
335,815
-13.8% QoQ
Ownership
0.691%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 45 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HOWL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. HOWL ranks #434 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in HOWL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,893 | 335,815 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $324,441 | 389,487 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $212,951 | 335,886 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $651,650 | 330,787 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $357,470 | 327,955 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $697,432 | 717,524 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,039,785 | 702,558 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,454,295 | 685,989 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,574,524 | 645,297 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,682,726 | 259,680 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $750,028 | 194,308 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $372,895 | 174,250 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $504,210 | 165,315 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $337,563 | 129,832 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $266,155 | 129,832 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $542,494 | 120,287 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $324,255 | 79,280 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,268,542 | 288,305 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,551,407 | 214,224 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,341,859 | 136,472 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,886,624 | 108,178 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||